Equities

N4 Pharma PLC

N4P:LSE

N4 Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.425
  • Today's Change0.00 / 0.00%
  • Shares traded1.02m
  • 1 Year change-72.58%
  • Beta-0.9370
Data delayed at least 20 minutes, as of Jul 05 2024 15:08 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, July 05, 2024Fri, Jul 05, 20240.450.450.400.4251,015,2431.02m
Thursday, July 04, 2024Thu, Jul 04, 20240.4250.450.400.425458,137458.14k
Wednesday, July 03, 2024Wed, Jul 03, 20240.4250.460.400.425179,339179.34k
Tuesday, July 02, 2024Tue, Jul 02, 20240.4250.450.450.42511,11011.11k
Monday, July 01, 2024Mon, Jul 01, 20240.4250.450.400.425249,038249.04k
Friday, June 28, 2024Fri, Jun 28, 20240.4250.450.400.425487,839487.84k
Thursday, June 27, 2024Thu, Jun 27, 20240.4250.450.3650.4251,689,8611.69m
Wednesday, June 26, 2024Wed, Jun 26, 20240.4750.450.400.42592,69892.70k
Tuesday, June 25, 2024Tue, Jun 25, 20240.4750.450.400.425841,536841.54k
Monday, June 24, 2024Mon, Jun 24, 20240.5250.500.400.4254,748,4124.75m
Friday, June 21, 2024Fri, Jun 21, 20240.5250.600.600.52510,00010.00k
Thursday, June 20, 2024Thu, Jun 20, 20240.5250.5250.5250.52500.00
Wednesday, June 19, 2024Wed, Jun 19, 20240.500.5500.5230.525160,928160.93k
Tuesday, June 18, 2024Tue, Jun 18, 20240.500.5500.450.50115,028115.03k
Monday, June 17, 2024Mon, Jun 17, 20240.500.5500.450.504,3084.31k
Friday, June 14, 2024Fri, Jun 14, 20240.5250.500.450.503,063,0463.06m
Thursday, June 13, 2024Thu, Jun 13, 20240.5250.5500.500.52594,45494.45k
Wednesday, June 12, 2024Wed, Jun 12, 20240.5500.600.500.525224,399224.40k
Tuesday, June 11, 2024Tue, Jun 11, 20240.5500.600.500.550351,884351.88k
Monday, June 10, 2024Mon, Jun 10, 20240.5500.600.500.550671,024671.02k
Friday, June 07, 2024Fri, Jun 07, 20240.6250.600.49990.55011,153,48111.15m
Data delayed at least 20 minutes, as of Jul 05 2024 16:08 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.